Expression of splicing variants of the inhibitor of apoptosis livin in testicular germ cell tumors

Tumor Biology

Volumn 29, Issue 2, 2008, Pages 76-82

  Kempkensteffen, Carsten ^a   Hinz, Stefan ^a   Krause, Hans ^a   Jäger, Tobias ^b   Köllermann, Jens ^c   Weikert, Steffen ^a   Christoph, Frank ^a   Schostak, Martin ^a   Miller, Kurt ^a   Schrader, Mark ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b UNIVERSITY OF DUISBURG ESSEN   (Germany)

^c UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Apoptosis; Embryonal carcinomas; Germ cell tumors; Inhibitor; Livin; Splicing variants; Testicular germ cell tumor

Indexed keywords

INHIBITOR OF APOPTOSIS PROTEIN; PROTEIN LIVIN ALPHA;

APOPTOSIS; ARTICLE; CANCER STAGING; CARCINOGENESIS; CONTROLLED STUDY; CORRELATION COEFFICIENT; EMBRYONAL CARCINOMA; GERM CELL TUMOR; GROUPS BY AGE; HISTOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEMINOMA; TESTIS; WESTERN BLOTTING;

EID: 47949125012     PISSN: 10104283     EISSN: None     Source Type: Journal    
DOI: 10.1159/000135687     Document Type: Article

References (48)

1. Print CG, Loveland KL: Germ cell suicide: new insights into apoptosis during spermatogenesis. Bioessays 2000;22:423-430.
2. Pentikainen V, Dunkel L, Erkkila K: Male germ cell apoptosis. Endocr Dev 2003;5:56-80.
3. Lin WW, Lamb DJ, Wheeler TM, Lipshultz LI, Kim ED: In situ end-labeling of human testicular tissue demonstrates increased apoptosis in conditions of abnormal spermatogenesis. Fertil Steril 1997;68:1065-1069.
4. Kim SK, Yoon YD, Park YS, Seo JT, Kim JH: Involvement of the Fas-Fas ligand system and active caspase-3 in abnormal apoptosis in human testes with maturation arrest and Sertoli cell-only syndrome. Fertil Steril 2007;87:547-553.
5. Kempkensteffen C, Jager T, Bub J, Weikert S, Hinz S, Christoph F, Krause H, Schostak M, Miller K, Schrader M: The equilibrium of XIAP and Smac/DIABLO expression is gradually deranged during the development and progression of testicular germ cell tumours. Int J Androl 2007.
6. Sano M, Nakanishi Y, Yagasaki H, Honma T, Oinuma T, Obana Y, Suzuki A, Nemoto N: Overexpression of anti-apoptotic Mcl-1 in testicular germ cell tumours. Histopathology 2005;46:532-539.
7. Chaganti RS, Houldsworth J: Genetics and biology of adult human male germ cell tumors. Cancer Res 2000;60:1475-1482.
8. Deveraux QL, Reed JC: IAP family proteins - suppressors of apoptosis. Genes Dev 1999;13:239-252.
9. Salvesen GS, Duckett CS: IAP proteins: blocking the road to death's door. Nat Rev Mol Cell Biol 2002;3:401-410.
10. Deveraux QL, Stennicke HR, Salvesen GS, Reed JC: Endogenous inhibitors of caspases. J Clin Immunol 1999;19:388-398.
11. Schimmer AD, Dalili S: Targeting the IAP family of caspase inhibitors as an emerging therapeutic strategy. Hematology Am Soc Hematol Educ Program 2005, pp 215-219.
12. Nachmias B, Ashhab Y, Ben-Yehuda D: The inhibitor of apoptosis protein family (IAPs): an emerging therapeutic target in cancer. Semin Cancer Biol 2004;14:231-243.
13. LaCasse EC, Baird S, Korneluk RG, MacKenzie AE: The inhibitors of apoptosis (IAPs) and their emerging role in cancer. Oncogene 1998;17:3247-3259.
14. Vucic D, Stennicke HR, Pisabarro MT, Salvesen GS, Dixit VM: ML-IAP, a novel inhibitor of apoptosis that is preferentially expressed in human melanomas. Curr Biol 2000;10:1359-1366.
15. Lin JH, Deng G, Huang Q, Morser J: KIAP, a novel member of the inhibitor of apoptosis protein family. Biochem Biophys Res Commun 2000;279:820-831.
16. Kasof GM, Gomes BC: Livin, a novel inhibitor of apoptosis protein family member. J Biol Chem 2001;276:3238-3246.
17. Ashhab Y, Alian A, Polliack A, Panet A, Ben Yehuda D: Two splicing variants of a new inhibitor of apoptosis gene with different biological properties and tissue distribution pattern. FEBS Lett 2001;495:56-60.
18. Crnkovic-Mertens I, Semzow J, Hoppe-Seyler F, Butz K: Isoform-specific silencing of the livin gene by RNA interference defines livin beta as key mediator of apoptosis inhibition in HeLa cells. J Mol Med 2006;84:232-240.
19. Ma L, Huang Y, Song Z, Feng S, Tian X, Du W, Qiu X, Heese K, Wu M: Livin promotes Smac/DIABLO degradation by ubiquitin-proteasome pathway. Cell Death Differ 2006;13:2079-2088.
20. Vucic D, Deshayes K, Ackerly H, Pisabarro MT, Kadkhodayan S, Fairbrother WJ, Dixit VM: SMAC negatively regulates the anti-apoptotic activity of melanoma inhibitor of apoptosis (ML-IAP). J Biol Chem 2002;277:12275-12279.
21. Choi J, Hwang YK, Sung KW, Lee SH, Yoo KH, Jung HL, Koo HH, Kim HJ, Kang HJ, Shin HY, Ahn HS: Expression of Livin, an antiapoptotic protein, is an independent favorable prognostic factor in childhood acute lymphoblastic leukemia. Blood 2007;109:471-477.
22. Gazzaniga P, Gradilone A, Giuliani L, Gandini O, Silvestri I, Nofroni I, Saccani G, Frati L, Agliano AM: Expression and prognostic significance of livin, survivin and other apoptosis-related genes in the progression of superficial bladder cancer. Ann Oncol 2003;14:85-90.
23. Hariu H, Hirohashi Y, Torigoe T, Asanuma H, Hariu M, Tamura Y, Aketa K, Nabeta C, Nakanishi K, Kamiguchi K, Mano Y, Kitamura H, Kobayashi J, Tsukahara T, Shijubo N, Sato N: Aberrant expression and potency as a cancer immunotherapy target of inhibitor of apoptosis protein family, livin/ML-IAP in lung cancer. Clin Cancer Res 2005;11:1000-1009.
24. Kempkensteffen C, Hinz S, Christoph F, Krause H, Koellermann J, Magheli A, Schrader M, Schostak M, Miller K, Weikert S: Expression of the apoptosis inhibitor livin in renal cell carcinomas: correlations with pathology and outcome. Tumor Biol 2007;28:132-138.
25. Tanabe H, Yagihashi A, Tsuji N, Shijubo Y, Abe S, Watanabe N: Expression of survivin mRNA and livin mRNA in non-small-cell lung cancer. Lung Cancer 2004;46:299-304.
26. Xiang Y, Yao H, Wang S, Hong M, He J, Cao S, Min H, Song E, Guo X: Prognostic value of survivin and livin in nasopharyngeal carcinoma. Laryngoscope 2006;116:126-130.
27. Crnkovic-Mertens I, Hoppe-Seyler F, Butz K: Induction of apoptosis in tumor cells by siRNA-mediated silencing of the livin/ML-IAP/KIAP gene. Oncogene 2003;22:8330-8336.
28. Nachmias B, Ashhab Y, Bucholtz V, Drize O, Kadouri L, Lotem M, Peretz T, Mandelboim O, Ben-Yehuda D: Caspase-mediated cleavage converts livin from an antiapoptotic to a proapoptotic factor: implications for drug-resistant melanoma. Cancer Res 2003;63:6340-6349.
29. Weikert S, Schrader M, Muller M, Krause H, Miller K: Expression of the apoptosis inhibitor survivin in testicular tissue of infertile patients. Int J Androl 2004;27:161-165.
30. Holstein AF, Schulze W, Davidoff M: Understanding spermatogenesis is a prerequisite for treatment. Reprod Biol Endocrinol 2003;1:107.
31. Johnsen SG: Testicular biopsy score count - a method for registration of spermatogenesis in human testes: normal values and results in 335 hypogonadal males. Hormones 1970;1:2-25.
32. Karge WH 3rd, Schaefer EJ, Ordovas JM: Quantification of mRNA by polymerase chain reaction (PCR) using an internal standard and a nonradioactive detection method. Methods Mol Biol 1998;110:43-61.
33. Liu B, Han M, Wen JK, Wang L: Livin/ML-IAP as a new target for cancer treatment. Cancer Lett 2007;250:168-176.
34. Looijenga LH, Oosterhuis JW: Pathogenesis of testicular germ cell tumours. Rev Reprod 1999;4:90-100.
35. Weikert S, Schrader M, Krause H, Schulze W, Muller M, Miller K: The inhibitor of apoptosis (IAP) survivin is expressed in human testicular germ cell tumors and normal testes. Cancer Lett 2005;223:331-337.
36. Weikert S, Schrader M, Christoph F, Schulze W, Krause H, Muller M, Miller K: Quantification of survivin mRNA in testes of infertile patients and in testicular germ cell tumours: high levels of expression associated with normal spermatogenesis. Int J Androl 2005;28:224-229.
37. Glinsky GV, Glinsky VV, Ivanova AB, Hueser CJ: Apoptosis and metastasis: increased apoptosis resistance of metastatic cancer cells is associated with the profound deficiency of apoptosis execution mechanisms. Cancer Lett 1997;115:185-193.
38. Gong J, Chen N, Zhou Q, Yang B, Wang Y, Wang X: Melanoma inhibitor of apoptosis protein is expressed differentially in melanoma and melanocytic naevus, but similarly in primary and metastatic melanomas. J Clin Pathol 2005;58:1081-1085.
39. di Pietro A, Vries EG, Gietema JA, Spierings DC, de Jong S: Testicular germ cell tumours: the paradigm of chemo-sensitive solid tumours. Int J Biochem Cell Biol 2005;37:2437-2456.
40. Kollmannsberger C, Mayer F, Kuczyk M, Kanz L, Bokemeyer C: Treatment of patients with metastatic germ cell tumors relapsing after high-dose chemotherapy. World J Urol 2001;19:120-125.
41. Perez RP: Cellular and molecular determinants of cisplatin resistance. Eur J Cancer 1998;34:1535-1542.
42. Mueller T, Voigt W, Simon H, Fruehauf A, Bulankin A, Grothey A, Schmoll HJ: Failure of activation of caspase-9 induces a higher threshold for apoptosis and cisplatin resistance in testicular cancer. Cancer Res 2003;63:513-521.
43. Vucic D, Franklin MC, Wallweber HJ, Das K, Eckelman BP, Shin H, Elliott LO, Kadkhodayan S, Deshayes K, Salvesen GS, Fairbrother WJ: Engineering ML-IAP to produce an extraordinarily potent caspase 9 inhibitor: implications for Smac-dependent anti-apoptotic activity of ML-IAP. Biochem J 2005;385:11-20.
44. Crnkovic-Mertens I, Muley T, Meister M, Hartenstein B, Semzow J, Butz K, Hoppe-Seyler F: The anti-apoptotic livin gene is an important determinant for the apoptotic resistance of non-small cell lung cancer cells. Lung Cancer 2006;54:135-142.
45. Crnkovic-Mertens I, Wagener N, Semzow J, Grone EF, Haferkamp A, Hohenfellner M, Butz K, Hoppe-Seyler F: Targeted inhibition of livin resensitizes renal cancer cells towards apoptosis. Cell Mol Life Sci 2007;64:1137-1144.
46. Yagihashi A, Asanuma K, Tsuji N, Torigoe T, Sato N, Hirata K, Watanabe N: Detection of anti-livin antibody in gastrointestinal cancer patients. Clin Chem 2003;49:1206-1208.
47. Yagihashi A, Ohmura T, Asanuma K, Kobayashi D, Tsuji N, Torigoe T, Sato N, Hirata K, Watanabe N: Detection of autoantibodies to survivin and livin in sera from patients with breast cancer. Clin Chim Acta 2005;362:125-130.
48. Yagihashi A, Asanuma K, Kobayashi D, Tsuji N, Shijubo Y, Abe S, Hirohashi Y, Torigoe T, Sato N, Watanabe N: Detection of autoantibodies to livin and survivin in sera from lung cancer patients. Lung Cancer 2005;48:217-221.